Functional assessment through Transwell assays demonstrated that LYPD3 knockdown augmented the migration and invasion capabilities of HNSCC cells, whereas LYPD3 overexpression attenuated these abilities (Fig. 2g, h and Fig. S3a). This evidence concerns the gene LYPD3 and head and neck squamous cell carcinoma.